Feasibility of introducing a smartphone navigation application into the care of breast cancer patients (The FIONA Study).

Autor: Isakoff SJ; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA. sisakoff@mgh.harvard.edu., Said MR; Outcomes4Me Inc, One Beacon St, 15th Floor, Boston, MA, 02108, USA., Kwak AH; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA., Glieberman E; Outcomes4Me Inc, One Beacon St, 15th Floor, Boston, MA, 02108, USA., O'Rourke EA; Outcomes4Me Inc, One Beacon St, 15th Floor, Boston, MA, 02108, USA., Stroiney A; Outcomes4Me Inc, One Beacon St, 15th Floor, Boston, MA, 02108, USA., Spring LM; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA., Moy B; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA., Bardia A; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA., Horick N; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA., Peppercorn JM; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, USA.
Jazyk: angličtina
Zdroj: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jun; Vol. 199 (3), pp. 501-509. Date of Electronic Publication: 2023 Apr 27.
DOI: 10.1007/s10549-023-06918-y
Abstrakt: Purpose: Patients with breast cancer (BC) face complex medical information and decisions. The Outcomes4Me mobile app provides evidence-based BC education, symptom management tracking and clinical trial matching. This study sought to evaluate the feasibility of introducing this app into routine BC care.
Methods: In this pilot study among BC patients undergoing therapy at an academic cancer center, patients were followed for 12 weeks with survey administration and electronic health record (EHR) abstraction at baseline and completion. Feasibility was defined as 40% of patients engaging with the app 3 or more times during the study. Additional endpoints included app usability (system usability scale), patient care experience, symptom evaluation, and clinical trial matching.
Results: The study enrolled 107 patients from 6/01/2020 to 3/31/2021. Utilization of the app was deemed feasible with 60% of patients engaging with the app at least 3 times. SUS score of 70 indicated above average usability. New diagnosis and higher education level was associated with greater app engagement, with usability similar across all age groups. 41% of patients found the app helped track symptoms. Cognitive and sexual symptoms were infrequently reported, but were more frequently captured in the app than in the EHR. After using the app, 33% of patients reported increased interest in clinical trial enrollment.
Conclusion: Introducing the Outcomes4Me patient navigation app into routine BC care is feasible and may improve the patient experience. These results support further evaluation of this mobile technology platform to improve BC education, symptom management, and decision making.
Clinical Trial Registry: Clinicaltrials.gov registration #: NCT04262518.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: